Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens." title="" class="btn" data-container="body" data-html="true" data-id="256627" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="GLOX Therapeutics Ltd."> 746
Activities
Technologies
Entity types
Location
Glasgow, UK
Glasgow
United Kingdom
Employees
Scale: 2-10
Estimated: 7
Engaged corporates
0Added in Motherbase
1 month, 2 weeks agoPrecision Protein Antibiotics
Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.